Camille Amparo
Papers
1
Total Citations
6
H-Index
1
About
Camille Amparo is a biomedical researcher whose work focuses on improving the prediction of prostate cancer recurrence, particularly after radical prostatectomy. Her key research areas include biomarker integration, machine learning classification, and the clinical application of novel diagnostic tests like PCA3 and PSA proteolytic activity. Amparo’s major contribution is the development of a two-stage classifier that combines these biomarkers to more accurately forecast early biochemical recurrence—a critical indicator of aggressive disease and cancer-specific death. By demonstrating how sequential testing can enhance predictive performance over single-marker approaches, her work addresses a pressing clinical need for risk stratification. Her most-cited paper, published in 2017, has garnered 6 citations, reflecting its niche but growing influence in urologic oncology. This study is notable for its practical, translational focus, aiming to guide postoperative surveillance and treatment decisions. Amparo’s research bridges computational modeling and clinical diagnostics, offering a pathway toward personalized management of prostate cancer patients. Her efforts underscore the value of integrating emerging biomarkers into actionable prognostic tools, making her a promising voice in the fight against cancer recurrence.
Research Focus
Key Achievements
Top Papers
- 1